Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes
about
Benzo(a)pyrene-caused increased G(1)-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblastsPractical uses for ecdysteroids in mammals including humans: an updateRas inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosisBIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cellsSuppression of AP1 transcription factor function in keratinocyte suppresses differentiationAge-related changes in redox signaling and VSMC function.Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activationDual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.Loss of E-cadherin-mediated cell-cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-JunInduction of p38δ expression plays an essential role in oncogenic ras-induced senescenceHuman TTC5, a novel tetratricopeptide repeat domain containing gene, activates p53 and inhibits AP-1 pathway.INMAP, a novel truncated version of POLR3B, represses AP-1 and p53 transcriptional activity.ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes-1 expression and synergistically activates the expression of Hes-1 in Notch-dependent neural progenitors.FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness.c-Jun-deficient cells undergo premature senescence as a result of spontaneous DNA damage accumulation.Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.c-jun/AP-1 activation does not affect the antiproliferative activity of phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent.Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells.Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2.Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.The proto-oncogene JUN is a target of the heat shock transcription factor HSF1.
P2860
Q23921356-EC3A2432-9510-47A8-9398-5A57F9A9D8F2Q24806380-441C4CB4-2B9B-461F-852A-1FEE60D6E5A4Q28287799-C556111A-EDC6-4DF0-A0E8-83C6BBE49306Q28478390-8442E9D9-2639-4469-BAD7-0D55448A3680Q28729714-BBF1A9DE-1828-4842-AF70-03B1DC7FD936Q33830145-23175E46-34D6-4DD7-B502-03BC0165A726Q36342526-BB4957BB-AA28-43DC-B074-76B339E330EEQ36376583-31D3D5C6-27E1-41DC-8E92-97B3F3F072DFQ36494199-E0E261D4-0205-444F-A2AF-3CA87B740563Q37146649-B43B34FD-8DBB-48BB-A4B3-29832B124305Q37264977-9D3F38E4-F5B6-4815-9A21-FD82006C6F78Q39087697-4364B049-2C8C-4599-9A79-221B9C70C35CQ39249666-1D1726EF-910D-4DE3-863A-980EF7C42270Q39753122-2D469D72-994F-4334-9E7E-CEB5B5874E71Q39975306-7D410777-4FB1-44F6-A26D-03278E50F094Q40025608-EB49AD56-B384-4439-9EA2-B8833914BF13Q40137705-925AF8AC-CC21-4534-9FCB-B1B62B8F4AC5Q40284610-C5E29BDF-8E81-46A8-9C5A-7EA33404DC7EQ40366542-1846BD5A-696C-42A0-81D2-1B78F0D9664EQ40402559-429D58A8-BE0F-48CB-9F0E-7FDEB733A2A2Q42248397-840950A7-27D4-4389-BDC3-A49D31EB8A23Q42321104-8063852C-8F92-44E4-B124-A26D09121464Q54239372-C3AEF513-2AA5-453B-BEBD-5E85B47DDCF4
P2860
Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@ast
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@en
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@nl
type
label
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@ast
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@en
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@nl
prefLabel
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@ast
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@en
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@nl
P2860
P356
P1476
Dominant negative c-jun inhibi ...... and cyclin E kinase complexes
@en
P2093
P J Stambrook
R F Hennigan
P2860
P304
P356
10.1091/MBC.12.8.2352
P407
P577
2001-08-01T00:00:00Z